Differentiation and localization of interneurons in the developing spinal cord depends on DOT1L expression.
Animals
Biomarkers
/ metabolism
Cell Differentiation
/ genetics
Cell Movement
Cell Proliferation
Chickens
Gene Expression Regulation, Developmental
Histone-Lysine N-Methyltransferase
/ deficiency
Homeodomain Proteins
/ metabolism
Integrases
/ metabolism
Interneurons
/ cytology
LIM-Homeodomain Proteins
/ metabolism
Mice, Transgenic
Neurogenesis
/ genetics
Spinal Cord
/ cytology
Stem Cells
/ metabolism
Transcription Factors
/ metabolism
Transcription, Genetic
Wnt1 Protein
/ metabolism
DOT1L
Epigenetics
Interneuron
Localization
Methyltransferase
Specification
Spinal cord
Journal
Molecular brain
ISSN: 1756-6606
Titre abrégé: Mol Brain
Pays: England
ID NLM: 101468876
Informations de publication
Date de publication:
29 05 2020
29 05 2020
Historique:
received:
10
02
2020
accepted:
18
05
2020
entrez:
31
5
2020
pubmed:
31
5
2020
medline:
9
7
2021
Statut:
epublish
Résumé
Genetic and epigenetic factors contribute to the development of the spinal cord. Failure in correct exertion of the developmental programs, including neurulation, neural tube closure and neurogenesis of the diverse spinal cord neuronal subtypes results in defects of variable severity. We here report on the histone methyltransferase Disruptor of Telomeric 1 Like (DOT1L), which mediates histone H3 lysine 79 (H3K79) methylation. Conditional inactivation of DOT1L using Wnt1-cre as driver (Dot1l-cKO) showed that DOT1L expression is essential for spinal cord neurogenesis and localization of diverse neuronal subtypes, similar to its function in the development of the cerebral cortex and cerebellum. Transcriptome analysis revealed that DOT1L deficiency favored differentiation over progenitor proliferation. Dot1l-cKO mainly decreased the numbers of dI1 interneurons expressing Lhx2. In contrast, Lhx9 expressing dI1 interneurons did not change in numbers but localized differently upon Dot1l-cKO. Similarly, loss of DOT1L affected localization but not generation of dI2, dI3, dI5, V0 and V1 interneurons. The resulting derailed interneuron patterns might be responsible for increased cell death, occurrence of which was restricted to the late developmental stage E18.5. Together our data indicate that DOT1L is essential for subtype-specific neurogenesis, migration and localization of dorsal and ventral interneurons in the developing spinal cord, in part by regulating transcriptional activation of Lhx2.
Identifiants
pubmed: 32471461
doi: 10.1186/s13041-020-00623-3
pii: 10.1186/s13041-020-00623-3
pmc: PMC7260853
doi:
Substances chimiques
Biomarkers
0
Evx1 protein, mouse
0
Homeodomain Proteins
0
LIM-Homeodomain Proteins
0
Lhx2 protein, mouse
0
Lhx9 protein, mouse
0
Transcription Factors
0
Wnt1 Protein
0
Dot1l protein, mouse
EC 2.1.1.-
Histone-Lysine N-Methyltransferase
EC 2.1.1.43
Cre recombinase
EC 2.7.7.-
Integrases
EC 2.7.7.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
85Références
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8218-23
pubmed: 22566624
PLoS One. 2014 Oct 28;9(10):e111076
pubmed: 25350849
Development. 2008 Dec;135(24):4153-64
pubmed: 19029045
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Neuron. 2008 Aug 14;59(3):413-24
pubmed: 18701067
Dev Biol. 2017 Dec 1;432(1):34-42
pubmed: 27742210
Nature. 2014 May 1;509(7498):43-8
pubmed: 24784215
Dev Biol. 2002 Apr 1;244(1):180-98
pubmed: 11900467
Front Mol Neurosci. 2015 Jun 16;8:25
pubmed: 26136656
Nat Genet. 2015 Jul;47(7):803-8
pubmed: 26005867
Development. 2007 Jan;134(2):357-66
pubmed: 17166926
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Neurobiol Dis. 2013 Jun;54:404-13
pubmed: 23376398
Neuron. 2002 May 16;34(4):535-49
pubmed: 12062038
Nucleic Acids Res. 2019 Jan 10;47(1):168-183
pubmed: 30329130
Development. 2019 Mar 27;146(12):
pubmed: 30846445
Blood. 2010 Nov 25;116(22):4483-91
pubmed: 20798234
Bioinformatics. 2019 Nov 1;35(22):4757-4759
pubmed: 31134269
Nat Commun. 2018 Aug 24;9(1):3436
pubmed: 30143612
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):7042-7
pubmed: 20348416
Mol Med Rep. 2018 Jun;17(6):8031-8038
pubmed: 29693124
Leukemia. 2014 Nov;28(11):2131-8
pubmed: 24854991
Nat Neurosci. 2004 May;7(5):510-7
pubmed: 15064766
Annu Rev Neurosci. 1998;21:309-45
pubmed: 9530499
Neuron. 2014 Apr 2;82(1):138-50
pubmed: 24698273
Biomolecules. 2018 Feb 27;8(1):
pubmed: 29495487
Neuron. 2001 Feb;29(2):367-84
pubmed: 11239429
Cell Death Differ. 2016 Apr;23(4):555-64
pubmed: 25526092
Neuron. 2008 Oct 9;60(1):84-96
pubmed: 18940590
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Dev Biol. 2013 Jul 15;379(2):229-34
pubmed: 23648512
Genome Biol. 2014;15(12):550
pubmed: 25516281
Int J Environ Res Public Health. 2013 Sep 17;10(9):4352-89
pubmed: 24048206
Neuron. 2013 Dec 18;80(6):1407-20
pubmed: 24360544
Cell. 1996 Jan 26;84(2):309-20
pubmed: 8565076
J Clin Invest. 2017 May 1;127(5):1918-1931
pubmed: 28394257
Elife. 2017 Aug 29;6:
pubmed: 28850031
Front Mol Neurosci. 2017 May 26;10:157
pubmed: 28603487
Mol Neurobiol. 2019 Jun;56(6):4273-4287
pubmed: 30302725
Front Cell Neurosci. 2014 Oct 09;8:293
pubmed: 25346659
Development. 2010 Sep 1;137(17):2915-25
pubmed: 20667911
Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19464-19473
pubmed: 31488723
Cell Cycle. 2014;13(5):726-38
pubmed: 24526115
Neuron. 2004 May 13;42(3):375-86
pubmed: 15134635
Cell. 2014 Dec 4;159(6):1417-1432
pubmed: 25467445
Differentiation. 2013 Jan;85(1-2):55-66
pubmed: 23328540
Development. 2016 Oct 1;143(19):3434-3448
pubmed: 27702783
Front Mol Neurosci. 2012 Jun 06;5:71
pubmed: 22685427
Neuron. 2007 Mar 15;53(6):813-27
pubmed: 17359917
J Comp Neurol. 2004 Mar 1;470(2):210-9
pubmed: 14750162
Nature. 2012 Aug 30;488(7413):642-6
pubmed: 22932389
Chromosoma. 2016 Sep;125(4):593-605
pubmed: 26728620
Development. 2007 Oct;134(19):3427-36
pubmed: 17728344
Lancet Neurol. 2013 Aug;12(8):799-810
pubmed: 23790957
Neuron. 2014 May 7;82(3):573-86
pubmed: 24726382
PLoS Genet. 2008 Sep 12;4(9):e1000190
pubmed: 18787701
J Neurophysiol. 2012 Jun;107(12):3256-66
pubmed: 22442567
Genes Dev. 2011 Jul 1;25(13):1345-58
pubmed: 21724828
Neuron. 2001 May;30(2):411-22
pubmed: 11395003
Annu Rev Genet. 2014;48:583-611
pubmed: 25292356
J Neurochem. 2016 May;137(3):371-83
pubmed: 26896748
PLoS One. 2014 Nov 25;9(11):e113308
pubmed: 25423083
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Neuron. 2015 Mar 18;85(6):1289-304
pubmed: 25789756
Neuron. 2010 Mar 25;65(6):886-98
pubmed: 20346763
Cell. 1999 Jun 25;97(7):903-15
pubmed: 10399918
Neuron. 2001 Aug 2;31(2):219-32
pubmed: 11502254
Neuron. 2013 Apr 10;78(1):191-204
pubmed: 23583114
Genes Dev. 2005 Mar 15;19(6):733-43
pubmed: 15769945
Neuron. 2002 May 16;34(4):551-62
pubmed: 12062039
J Biol Chem. 2010 Nov 19;285(47):36922-32
pubmed: 20833714
Nature. 1999 Apr 15;398(6728):622-7
pubmed: 10217145
Stem Cells. 2016 Jan;34(1):233-45
pubmed: 26299268
Genes Dev. 2002 May 15;16(10):1220-33
pubmed: 12023301
Mol Med Rep. 2016 Jan;13(1):99-106
pubmed: 26548512
Dev Neurobiol. 2015 Nov;75(11):1189-203
pubmed: 25649879
Science. 2015 Oct 30;350(6260):550-4
pubmed: 26516282
Development. 1998 Mar;125(5):919-28
pubmed: 9449674
Oncotarget. 2016 Jun 21;7(25):37436-37455
pubmed: 27224923
Development. 2004 Aug;131(15):3693-703
pubmed: 15229182
Nat Neurosci. 2006 Jun;9(6):770-8
pubmed: 16715081